Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Shore

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|June 11, 2020
Cord blood transplants supported by unrelated donor CD34<sup>+</sup> progenitor cellsAlexandra Gomez-Arteaga, Nina Orfali, Danielle Guarneri, et al.
Transplantation and Cellular Therapy|September 7, 2024
Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+ selected Cells [Haplo-Cord] Versus Matched Donors)Nima Ghalehsari, Franco Castillo Tokumori, Zhengming Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 8, 2018
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell TransplantationFrancisco M Marty, Drew J Winston, Roy F Chemaly, et al.
Leukemia & Lymphoma|August 25, 2012
Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignanciesMichael J Satlin, David P Calfee, Liang Chen, et al.
Bone Marrow Transplantation|June 14, 2019
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myelomaAlexandra Gomez-Arteaga, Tomer M Mark, Danielle Guarneri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donorsPatrick J Stiff, William Bensinger, Muneer H Abidi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2017
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic LeukemiaJingmei Hsu, Andrew Artz, Sebastian A Mayer, et al.
Leukemia & Lymphoma|February 12, 2019
Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high riskKoen Van Besien, Lizamarie Bachier-Rodriguez, Michael Satlin, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 16, 2015
Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancySamantha E Jacobs, Daryl M Lamson, Rosemary Soave, et al.
Transplantation and Cellular Therapy|November 5, 2022
Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab RecipientsChandni Patel, Michelle Pasciolla, Rachel Abramova, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|June 11, 2020
Cord blood transplants supported by unrelated donor CD34<sup>+</sup> progenitor cellsAlexandra Gomez-Arteaga, Nina Orfali, Danielle Guarneri, et al.
Transplantation and Cellular Therapy|September 7, 2024
Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+ selected Cells [Haplo-Cord] Versus Matched Donors)Nima Ghalehsari, Franco Castillo Tokumori, Zhengming Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 8, 2018
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell TransplantationFrancisco M Marty, Drew J Winston, Roy F Chemaly, et al.
Leukemia & Lymphoma|August 25, 2012
Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignanciesMichael J Satlin, David P Calfee, Liang Chen, et al.
Bone Marrow Transplantation|June 14, 2019
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myelomaAlexandra Gomez-Arteaga, Tomer M Mark, Danielle Guarneri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donorsPatrick J Stiff, William Bensinger, Muneer H Abidi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2017
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic LeukemiaJingmei Hsu, Andrew Artz, Sebastian A Mayer, et al.
Leukemia & Lymphoma|February 12, 2019
Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high riskKoen Van Besien, Lizamarie Bachier-Rodriguez, Michael Satlin, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 16, 2015
Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancySamantha E Jacobs, Daryl M Lamson, Rosemary Soave, et al.
Transplantation and Cellular Therapy|November 5, 2022
Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab RecipientsChandni Patel, Michelle Pasciolla, Rachel Abramova, et al.
Pageof 8